Earnings Feed
Sign Up
Home/Filings/4/0001209191-11-028899
4//SEC Filing

Cardiogenesis Corp /CA 4

Accession 0001209191-11-028899

CIK 0000863680operating
View on SEC.govCompany Profile

Filed

May 16, 8:00 PM ET

Accepted

May 17, 2:40 PM ET

Size

31.9 KB

Accession

0001209191-11-028899

Insider Transaction Report

Form 4
Period: 2011-05-17
Cardiogenesis Corp /CACGCP.PK
LANIGAN RICHARD P
President
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17−14,583→ 0 total
    Exercise: $0.91Exp: 2012-05-31→ Common Stock (14,583 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17$0.16/sh−150,000$23,550→ 0 total
    Exercise: $0.30Exp: 2017-01-03→ Common Stock (150,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17−83,333→ 0 total
    Exercise: $0.70Exp: 2013-06-24→ Common Stock (83,333 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17−50,000→ 0 total
    Exercise: $1.03Exp: 2014-02-26→ Common Stock (50,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17−100,000→ 0 total
    Exercise: $0.50Exp: 2016-03-21→ Common Stock (100,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17$0.14/sh−58,802$8,056→ 0 total
    Exercise: $0.32Exp: 2013-01-07→ Common Stock (58,802 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17−16,667→ 0 total
    Exercise: $0.70Exp: 2013-06-24→ Common Stock (16,667 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17−75,000→ 0 total
    Exercise: $0.54Exp: 2015-01-14→ Common Stock (75,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17−13,890→ 0 total
    Exercise: $1.01Exp: 2011-08-02→ Common Stock (13,890 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17−22,917→ 0 total
    Exercise: $0.91Exp: 2012-05-31→ Common Stock (22,917 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17$0.14/sh−74,332$10,183→ 0 total
    Exercise: $0.32Exp: 2013-01-07→ Common Stock (74,332 underlying)
  • Disposition to Issuer

    Common Stock

    2011-05-17−231,895→ 0 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17−11,110→ 0 total
    Exercise: $1.01Exp: 2011-08-02→ Common Stock (11,110 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2011-05-17$0.33/sh−250,000$81,750→ 0 total
    Exercise: $0.13Exp: 2019-02-23→ Common Stock (250,000 underlying)
Footnotes (2)
  • [F1]Disposed of pursuant to that certain Amended and Restated Agreement and Plan of Merger, dated April 14, 2011, by and among CryoLife, Inc., CL Falcon, Inc., and Cardiogenesis Corporation in exchange for cash consideration equal to $0.457 per share on the effective date of the merger (the "Merger"). This transaction is exempt under Rule 16b-3(e).
  • [F2]Option cancelled pursuant to the Merger in exchange for cash consideration equal to the difference between $0.457 and the exercise price of the Option multiplied by the number of Options canceled. This transaction is exempt under Rule 16b-3(e).

Documents

1 file

Issuer

Cardiogenesis Corp /CA

CIK 0000863680

→
Entity typeoperating
IncorporatedCA

Related Parties

1
  • filerCIK 0000863680

Filing Metadata

Form type
4
Filed
May 16, 8:00 PM ET
Accepted
May 17, 2:40 PM ET
Size
31.9 KB
View on SEC.gov